Substituted biphenyl GPR40 modulators

Details Substituted biphenyl GPR40 modulators Substituted biphenyl GPR40 modulators

2008-04-10

2009-08-11

Puttlitz, Karl J (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carboxylic acids and salts thereof

C564S026000, C514S277000, C514S568000

Reexamination Certificate

active

07572934

ABSTRACT:
The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I:where the definitions of the variables are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.

REFERENCES:
patent: 3507881 (1970-04-01), Sandberg et al.
patent: 4760089 (1988-07-01), Chambers et al.
patent: 6037367 (2000-03-01), Christensen, IV et al.
patent: 6506757 (2003-01-01), Tajima et al.
patent: 6620832 (2003-09-01), Eastwood
patent: 6645939 (2003-11-01), Durette et al.
patent: 6710063 (2004-03-01), Chao et al.
patent: 6723740 (2004-04-01), Chao et al.
patent: 6875780 (2005-04-01), Auerbach et al.
patent: 6939875 (2005-09-01), Auerbach et al.
patent: 6964983 (2005-11-01), Auerbach et al.
patent: 7338960 (2008-03-01), Bell et al.
patent: 7345068 (2008-03-01), Endou et al.
patent: 2004/0058965 (2004-03-01), Momose et al.
patent: 2005/0089866 (2005-04-01), Hinuma et al.
patent: 2005/0119256 (2005-06-01), Endo et al.
patent: 2006/0003344 (2006-01-01), Houseknecht et al.
patent: 2006/0004012 (2006-01-01), Akerman et al.
patent: 2006/0270724 (2006-11-01), Houze et al.
patent: 2007/0066647 (2007-03-01), Akerman et al.
patent: 2007/0149608 (2007-06-01), Yasuma et al.
patent: 2007/0244155 (2007-10-01), Sharma et al.
patent: 2007/0265332 (2007-11-01), Ge et al.
patent: 2008/0090840 (2008-04-01), Beck et al.
patent: 2008/0119511 (2008-05-01), Brown et al.
patent: A 27141/77 (1979-01-01), None
patent: A 52306/93 (1994-06-01), None
patent: 2111035 (1994-06-01), None
patent: 199 4 1 567 (2000-04-01), None
patent: 0 250 264 (1987-12-01), None
patent: 0 414 289 (1994-02-01), None
patent: 1 357 115 (2003-10-01), None
patent: 1 380 562 (2004-01-01), None
patent: 1 535 915 (2005-06-01), None
patent: 1 559 422 (2005-08-01), None
patent: 1559422 (2005-08-01), None
patent: 1 630 152 (2006-03-01), None
patent: 10316641 (1998-02-01), None
patent: 2001242165 (2001-09-01), None
patent: 2002003368 (2002-01-01), None
patent: WO 93/23040 (1993-11-01), None
patent: WO 93/23041 (1993-11-01), None
patent: WO 95/01326 (1995-01-01), None
patent: WO 95/01348 (1995-01-01), None
patent: WO 97/12867 (1997-04-01), None
patent: WO 99/11255 (1999-03-01), None
patent: WO 01/00603 (2001-01-01), None
patent: WO 01/36351 (2001-05-01), None
patent: WO 01/36365 (2001-05-01), None
patent: WO 02/057783 (2002-07-01), None
patent: WO 02/062774 (2002-08-01), None
patent: WO 00/63196 (2002-10-01), None
patent: WO 02/100403 (2002-12-01), None
patent: WO 03/074050 (2003-09-01), None
patent: WO 03/099793 (2003-12-01), None
patent: WO 04/000315 (2003-12-01), None
patent: WO 2004/092117 (2004-10-01), None
patent: WO 2004/106276 (2004-12-01), None
patent: WO 2005/051890 (2005-06-01), None
patent: WO 2005/058848 (2005-06-01), None
patent: WO 2005/063725 (2005-07-01), None
patent: WO 2005/063729 (2005-07-01), None
patent: WO 2005/087710 (2005-09-01), None
patent: WO 2006/001092 (2006-01-01), None
patent: WO 2006/011615 (2006-02-01), None
patent: WO 2006/083612 (2006-08-01), None
patent: WO 2006/083781 (2006-08-01), None
patent: WO 2007/123225 (2007-11-01), None
patent: WO 2007/131619 (2007-11-01), None
patent: WO 2007/131620 (2007-11-01), None
patent: WO 2007/131622 (2007-11-01), None
Bachmann, W. E. et al., “The Synthesis of an Analog of the Sex Hormones,”J. Am. Chem. Soc., 64, 94-97 (1942).
Berthelot et al., “Synthesis and Pharmacological Evaluation of y-Aminobutyric Acid Analogues. New Ligand for GABABSites,”J. Med. Chem., 30, 743-746 (1987).
Boyle, Thomas F. et al., “Applications of the Spiroannulation of Tetralins with Alkynes; Towards New Anti-Estrogenic Compounds,”J. Chem. Soc. Perkin Trans. I: Organic and Bioorganic Chem., 18, 2707-2711 (1997).
Briscoe et al., “The Orphan G Protein-Coupled Receptor GPR40 is Activated by Medium and Long Chain Fatty Acids,”J. of Biol. Chem., 278(13), 11303-11311 (2003).
Briscoe, C. P. et al., “Pharmacological Regulation of Insulin Secretion in MIN6 Cells Through the Fatty Acid Receptor GPR40: Identification of Agonist and Antagonist Small Molecules,”Brit. J. of Pharmacology, 148, 619-628 (2006).
Burnop, V.C.E. et al., “Fused Carbon Rings. Part XIX. Experiments on the Synthesis of Tetracyclic Compounds of the Sexual Hormonal Type,”J. Chem. Soc., 727-735 (1940).
Chatterjee, A., et al., “Studies on Nucleophilic Ring Opening of Some Epoxides in Polar Protic Solvents,”Tetrahedron, 33, 85-94 (1977).
Ray, Chhanda et al., “Synthesis of some angularly cyclopentanone fused hydrophenanthrene and hydrofluorene derivatives by acid-catalyzed intramolecular C-alkylation of γ, δ-unsaturated α′-diazomethyl ketones,”Synthetic Commun., 21(10-11), 1223-1242 (1991).
Collins, David J. et al., “The Structure and Function of Oestrogens. IX*. Synthesis of the trans Isomer of 5,5, 10b-Trimtehyl-4b,5,6,10b,11,12-hexahydrocvhrysene-2,8-diol,”Aust. J. Chem., 41, 735-744 (1988).
Deb, Soumitra et al., “A Stereocontrolled Synthesis of (1′RS, 2′SR)-3-oxo-3′,4′-dihydrospiro[cyclopentane-1,1′(2′H)-naphthalen]-2-yl Acetic Acid and its Methoxy Derivatives,”J. Chem. Res. Synops., 12, 406 (1985).
DeWolf et al., “Inactivation of Dopamine β-Hydroxylase by β-Ethynyltyramine: Kinetic Characterization and Covalent Modification of an Active Site Peptide,”Biochemistry, 28, 3833-3842 (1989).
Egan, R. W. et al., “Naphthalenes as Inhibitors of Myeloperoxidase: Direct and Indirect Mechanisms of Inhibition,”Agents and Actions, 29¾ 266-276 (1990).
Frey et al., “Total Synthesis of Pentacyclic Diterpenoid Tropone Hainanolidol,”Aust. J. Chemistry, 53, 819-830 (2000).
Galemmo et al., “The Development of a Novel Series of (Quinolin-2-ylmethoxy) phenyl-Containing Compounds as High-Affinity Leukotriene Receptor Antagonists. 3. Structural Variation of the Acidic Side Chain to Give Antagonists of Enhanced Potency,”J. Med. Chem., 33, 2828-2841 (1990).
Garrido, D. M., et al., “Synthesis and Activity of Small Molecule GPR40 Agonists,”Bioorg. and Med. Chem. Lett., 16, 1840-1845 (2006).
Ghosal, Probit Kumar, et al., “Stereospecific Synthesis of 9bβ-Carbomethoxy-7-methoxy-2,3,3aα,4,5,9bβ-Hexahydro-1H-Benz[e]-Inden-2-one; An Intermediate Towards Physiologically Active Compounds,”Tet. Lett., 17, 1463-1464 (1977).
Guthrie, R. W. et al., “Synthesis in the Series of Diterpene Alkaloids VI. A Simple Synthesis of Atisine,”Tet. Lett., 38, 4645-4654 (1966).
Haigh et al., “Non-thiazolidinedione Antihyperglycaemic Agents. Part 3: The Effects of Stereochemistry on the Potency of α-Methoxy-β-phenylpropanoic Acids,”Bioorg.&Med. Chem., 7, 821-830 (1999).
Hares, Owen et al., “Sythetic Studies of Tricyclospirodienones: Model Chemistry for Novel Mimics of Steroid Substrates,”J. Chem. Soc. Perkin Trans. I: Organic and Bioorganic Chem., 13, 1481-1492 (1993).
Iizuka et al., “β-Substituted Phenethylamines as High Affinity Mechanism-Based Inhibitors of Dopamine β-Hydroxylase,”J. Med. Chem., 31, 704-706 (1988).
Ishikawa et al., “Actions of the Novel Oral Antidiabetic Agent HQL-975 in Insulin-Resistant Non-Insulin -Dependent Diabetes Mellitus Model Animals,”Diabetes Res. and Clin. Pract., 41, 101-111 (1998).
Ishikawa et al., “Effects of the Novel Oral Antidiabetic Agent HQL-975 in Glucose and Lipid Metabolism in Diabetic db/db Mice,”Arzneim. Forsch. Drug Res., 48(3), 245-250 (1998).
Itoh et al., “Free Fatty Acids Regulate Insulin Secretion from Pancreatic β Cells Through GPR40,”Nature, 422, 173-176 (2003).
Johns, William F. et al., “Total Synthesis of Estrajervatetraene,”J. Org. Chem., 44(6), 958-961 (19

Affiliated with

Also associated with

Rating

Substituted biphenyl GPR40 modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted biphenyl GPR40 modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted biphenyl GPR40 modulators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4138062